Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Top 20 Pharma Report | Contract Pharma

What are you searching for?

Sign in
Features

Top 20 Pharma Report

Our annual look at the 20 biggest players in the Pharmaceutical marketplace

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

It was quite a strange year for our top pharmas. A top 10 company spun off its innovative pharma unit, the biggest acquisition came from a company at the bottom of our list (Gilead’s $11 billion purchase of Pharmasset and its hepatitis C pipeline), and the biggest launch came from a company that’s not even in the Top 20: Vertex, which posted almost $1 billion in revenues in seven months for HCV treatment Incivek.

The ranks were relatively stable, with minor shifts based on acquisition integrations. More often,  exchange rate fluctuations tweaked the results a bit, boosting companies that would otherwise look anemic or worse. The euro and krone both rose 5%, the British pound was up 4%, the yen was up 9%, and the Swiss franc blew up 18%.

For USD-reporting companies, total revenues rose 6% to $301.5 billion. The days of double-digits are long gone . . .

—Gil Y. Roth
Editor


Contributors
Editor: Gil Y. Roth
Associate Editor: Kristin Brooks
Contributing Editor: Derek B. Lowe

All profiles written by Gil Roth, except Astellas and Daiichi-Sankyo, by Kristin Brooks
The Lowe Down capsules written by Derek Lowe (http://pipeline.corante.com)
Pipeline information compiled by Kristin Brooks
Revenue information compiled by Gil Roth

Photo courtesy of Eli Lilly & Co.

Top 20 Pharmaceutical Companies 
based on 2011 pharma revenues

1

Pfizer 

$57,747
2

Novartis

$47,935
3

Sanofi

$42,779
4

Merck

$41,289
5

GlaxoSmithKline 

$35,594
6

AstraZeneca

$32,981
7

Johnson & Johnson

$24,368
8

Eli Lilly & Co.

$22,608
9

Abbott Laboratories

$22,435
10

Bristol-Myers Squibb

$21,244
11

Takeda Pharma

$17,257
12

Teva

$16,689
13

Boehringer-Ingelheim

$14,058
14

Bayer Schering

$13,853
15

Astellas

$12,311
16

Daiichi-Sankyo

$11,338
17

Otsuka Pharmaceutical

$9,935
18

Gilead Sciences

$8,102
19

EISAI 

$7,710
20

Mylan

$6,106

Note: In all Top Company profiles, dollar amounts are in millions.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics